The curative effect of some natural active compounds for liver cancer

Area of Science:

• Biochemistry
• Pharmacology
• Computational Chemistry

Background:

• Cancer, particularly liver cancer, presents a significant global health challenge requiring urgent development of effective treatments.
• Metastasis complicates cancer treatment, necessitating rapid identification of compounds that can target cancer cells effectively.
• Medicinal plants are a rich source of bioactive compounds with potential therapeutic applications.

Purpose of the Study:

• To computationally screen prominent active substances from medicinal plants for their efficacy against liver cancer.
• To utilize molecular docking scores to predict and identify compounds with high inhibitory effects on liver cancer receptors.
• To guide experimental research by pinpointing promising natural compounds for liver cancer treatment, saving time and resources.

Main Methods:

• Employing molecular docking simulations to assess the binding affinity of various plant-derived compounds to liver cancer receptors.
• Comparing docking scores of identified active substances to rank their potential inhibitory activity.
• Focusing on compounds known for their presence in medicinal plants with a history of therapeutic use.

Main Results:

• Cucurbitacin I and Cucurbitacin E demonstrated significant inhibitory potential against liver cancer cell receptors.
• Thymol, Piperine, and Carvacrol also exhibited strong predicted efficacy in docking analyses.
• The study successfully identified several natural compounds with high potential for inhibiting liver cancer progression.

Conclusions:

• Cucurbitacin I, Cucurbitacin E, Thymol, Piperine, and Carvacrol are identified as highly effective inhibitors of liver cancer cell receptors.
• Computational docking provides a valuable tool for rapidly screening natural products for anticancer activity.
• These findings provide a strong foundation for further experimental validation and drug development for liver cancer.